Changzhen Shang

2.3k total citations · 1 hit paper
65 papers, 1.7k citations indexed

About

Changzhen Shang is a scholar working on Hepatology, Molecular Biology and Surgery. According to data from OpenAlex, Changzhen Shang has authored 65 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hepatology, 25 papers in Molecular Biology and 20 papers in Surgery. Recurrent topics in Changzhen Shang's work include Hepatocellular Carcinoma Treatment and Prognosis (18 papers), Liver physiology and pathology (10 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers). Changzhen Shang is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (18 papers), Liver physiology and pathology (10 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers). Changzhen Shang collaborates with scholars based in China, United States and Macao. Changzhen Shang's co-authors include Yajin Chen, Min Jun, Haoming Lin, Lihong Lv, Yun-Le Wan, Wenliang Tan, Guolin Li, Yan Lin, Mei Yang and Wei Zhang and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Changzhen Shang

59 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lactylation‐Driven IGF2BP3‐Mediated Serine Metabolism Reprogramming and RNA m6A—Modification Promotes Lenvatinib Resistance in HCC

2024 55 citations Changzhen Shang, Wanguang Zhang et al. profile →

Peers

Changzhen Shang

ONCOL

HEPAT

SURGE

Ying‐Hao Shen China

Johann von Felden Germany

Laura Pelletier France

Tomoyuki Nagai Japan

Chunyi Hao China

Ja‐June Jang South Korea

Teresa García‐Lezana United States

Renumathy Dhanasekaran United States

Yuan‐Fei Peng China

Sang‐Hyun Song South Korea

Ying‐Hao Shen China

Changzhen Shang

571 ×0.6

418 ×0.7

413 ×0.9

ONCOL

499 ×1.2

HEPAT

270 ×1.1

SURGE

Citations per year, relative to Changzhen Shang Changzhen Shang (= 1×) peers Ying‐Hao Shen

Countries citing papers authored by Changzhen Shang

Since Specialization

Citations

This map shows the geographic impact of Changzhen Shang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changzhen Shang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changzhen Shang more than expected).

Fields of papers citing papers by Changzhen Shang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changzhen Shang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changzhen Shang. The network helps show where Changzhen Shang may publish in the future.

Co-authorship network of co-authors of Changzhen Shang

This figure shows the co-authorship network connecting the top 25 collaborators of Changzhen Shang. A scholar is included among the top collaborators of Changzhen Shang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changzhen Shang. Changzhen Shang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xie, Zhiqin, Qingbin Wang, Rong Huang, et al.. (2025). Epidemiological trends in gastrointestinal cancers and risk factors across U.S. states from 2000 to 2021: a systematic analysis for the global burden of disease study 2021. BMC Public Health. 25(1). 43–43. 2 indexed citations

Guo, Bin, Shuang Xie, X Y Feng, et al.. (2025). Long-Term Survival and Beneficiaries of Adjuvant Anti-PD-1 Therapy in Resected Hepatocellular Carcinoma. Annals of Surgical Oncology. 33(2). 1470–1480.

Chen, Yajin, Chengyou Du, Shunli Shen, et al.. (2024). Toripalimab Plus Bevacizumab as First-line Treatment for Advanced Hepatocellular Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Trial. Clinical Cancer Research. 30(14). 2937–2944. 7 indexed citations

Yang, Lei, Hongkai Zhuang, Xinming Chen, et al.. (2024). Lenvatinib inhibits cholangiocarcinoma progression by targeting the FGF19/PI3K/AKT signaling pathway. APOPTOSIS. 30(1-2). 185–196. 1 indexed citations

Zhuang, Hongkai, Qingbin Wang, Ziyu Zhang, et al.. (2024). CircNUP54 promotes hepatocellular carcinoma progression via facilitating HuR cytoplasmic export and stabilizing BIRC3 mRNA. Cell Death and Disease. 15(3). 191–191. 9 indexed citations

Wang, Qingbin, Wenliang Tan, Ziyu Zhang, et al.. (2024). FAT10 induces immune suppression by upregulating PD-L1 expression in hepatocellular carcinoma. APOPTOSIS. 29(9-10). 1529–1545. 4 indexed citations

Xie, Zhiqin, Hongxia Li, Ziyu Zhang, et al.. (2023). Trends in prevalence and all-cause mortality of metabolic dysfunction-associated fatty liver disease among adults in the past three decades: Results from the NHANES study. European Journal of Internal Medicine. 110. 62–70. 11 indexed citations

Wang, Qingbin, Hongkai Zhuang, Zhiqin Xie, et al.. (2023). Identification of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and Responsiveness to Immunotherapy in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 10. 1–16. 3 indexed citations

Peng, Xiaozhong, Huilong Li, Yunpeng Hua, et al.. (2023). A novel nomogram based on preoperative parameters to predict posthepatectomy liver failure in patients with hepatocellular carcinoma. Surgery. 174(4). 865–873. 4 indexed citations

10.

Zhuang, Hongkai, Lei Yang, Zhiqin Xie, et al.. (2022). SLC39A1 Overexpression is Associated with Immune Infiltration in Hepatocellular Carcinoma and Promotes Its Malignant Progression. SHILAP Revista de lepidopterología. 9 indexed citations

11.

Xie, Zhiqin, Hongxia Li, Wenliang Tan, et al.. (2022). Association of Serum Vitamin C With NAFLD and MAFLD Among Adults in the United States. Frontiers in Nutrition. 8. 795391–795391. 28 indexed citations

12.

Zhuang, Hongkai, Bo Chen, Xinming Chen, et al.. (2022). Identification of LSM Family Members as Novel Unfavorable Biomarkers in Hepatocellular Carcinoma. Frontiers in Oncology. 12. 871771–871771. 16 indexed citations

13.

Tan, Wenliang, Kelin Zhang, Xinming Chen, et al.. (2022). GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma. Journal of Advanced Research. 44. 173–183. 39 indexed citations

14.

Chen, Jie, Xicheng Wang, Xining Wang, et al.. (2020). A FITM1-Related Methylation Signature Predicts the Prognosis of Patients With Non-Viral Hepatocellular Carcinoma. Frontiers in Genetics. 11. 99–99. 4 indexed citations

15.

Zhou, Rui, Dihan Lu, Wenda Li, et al.. (2019). Is lymph node dissection necessary for resectable intrahepatic cholangiocarcinoma? A systematic review and meta-analysis. HPB. 21(7). 784–792. 66 indexed citations

16.

Feng, Ruibing, Yang Wang, Conghui Liu, et al.. (2018). Acetaminophen-induced liver injury is attenuated in transgenic fat-1 mice endogenously synthesizing long-chain n-3 fatty acids. Biochemical Pharmacology. 154. 75–88. 21 indexed citations

17.

Xiang, Qingfeng, Weiqiang Chen, Meng Ren, et al.. (2014). Cabozantinib Suppresses Tumor Growth and Metastasis in Hepatocellular Carcinoma by a Dual Blockade of VEGFR2 and MET. Clinical Cancer Research. 20(11). 2959–2970. 186 indexed citations

18.

Li, Wenda, Xue Zhou, Zejian Huang, et al.. (2014). Laparoscopic surgery minimizes the release of circulating tumor cells compared to open surgery for hepatocellular carcinoma. Surgical Endoscopy. 29(11). 3146–3153. 38 indexed citations

19.

Shang, Changzhen, Qiang Li, Nianfeng Sun, et al.. (2013). Epithelial-Mesenchymal Transition Delayed by E-cad to Promote Tissue Formation in Hepatic Differentiation of Mouse Embryonic Stem Cells In Vitro. Stem Cells and Development. 23(8). 877–887. 4 indexed citations

20.

Lv, Lihong, Yun-Le Wan, Yan Lin, et al.. (2012). Anticancer Drugs Cause Release of Exosomes with Heat Shock Proteins from Human Hepatocellular Carcinoma Cells That Elicit Effective Natural Killer Cell Antitumor Responses in Vitro. Journal of Biological Chemistry. 287(19). 15874–15885. 381 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact